Documentation Centre

 

 

  of 841 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans. J Lipid Res. 2014;55:1693-1701 October 24, 2014 Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans. J Lipid Res. 2014;55:1693-1701 Singaraja RR, Tietjen I, Hovingh GK, Franchini PL, Radomski C, Wong K, vanHeek M, Stylianou IM, Lin L, Wang L, Mitnaul L, Hubbard B, Winther M, Mattice M, Legendre A, Sherrington R, Kastelein JJ, Akinsanya K, Plump A, Hayden MR Key Publications
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J Am Coll Cardiol. 2014;64:485-94 October 23, 2014 Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials. J Am Coll Cardiol. 2014;64:485-94 Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM Jr, Ridker PM, Grundy SM, Kastelein JJ Key Publications
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349:g4379 October 20, 2014 Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients. BMJ. 2014;349:g4379 Keene D, Price C, Shun-Shin MJ, Francis DP Key Publications
Not so "good" cholesterol. BMJ. 2014;349:g4664 October 20, 2014 Not so "good" cholesterol. BMJ. 2014;349:g4664 Kritharides L Key Publications
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ. 2014;349:g4356 October 20, 2014 Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. BMJ. 2014;349:g4356 Rabar S, Harker M, O'Flynn N, Wierzbicki AS; Guideline Development Group Key Publications
Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice? Curr Opin Lipidol. 2014;25:321-3 October 13, 2014 Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice? Curr Opin Lipidol. 2014;25:321-3 Kalhan A, Rees A Key Publications
Comparison of cardiovascular disease risk calculators. Curr Opin Lipidol. 2014;25:254-65 October 10, 2014 Comparison of cardiovascular disease risk calculators. Curr Opin Lipidol. 2014;25:254-65 Allan GM, Garrison S, McCormack J Key Publications
Review of clinical practice guidelines for the management of LDL-related risk. J Am Coll Cardiol. 2014;64:196-206 October 09, 2014 Review of clinical practice guidelines for the management of LDL-related risk. J Am Coll Cardiol. 2014;64:196-206 Morris PB, Ballantyne CM, Birtcher KK, Dunn SP, Urbina EM Key Publications
Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease. Coron Artery Dis. 2014;25:433-8 October 07, 2014 Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease. Coron Artery Dis. 2014;25:433-8 Pan L, Lu G, Chen Z Key Publications
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-45 September 29, 2014 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S1-45 Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. Key Publications

  of 841 Next page

Go to page: of